Updates are available Correction dated 2021-09-01
Click to view Correction: https://doi.org/10.1038/s41584-021-00690-3
-
Authors
Barber, Megan R. W. http://orcid.org/0000-0003-1055-1335
Drenkard, Cristina http://orcid.org/0000-0002-6832-7291
Falasinnu, Titilola
Hoi, Alberta http://orcid.org/0000-0002-9416-7383
Mak, Anselm http://orcid.org/0000-0002-4688-7829
Kow, Nien Yee http://orcid.org/0000-0002-5492-3172
Svenungsson, Elisabet http://orcid.org/0000-0003-3396-3244
Peterson, Jonna http://orcid.org/0000-0001-6585-892X
Clarke, Ann E. http://orcid.org/0000-0002-3112-9646
Ramsey-Goldman, Rosalind http://orcid.org/0000-0001-8712-787X
- License Information
-
More Information
Article History
Accepted: 9 July 2021
First Online: 3 August 2021
Change Date: 1 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-021-00690-3
Competing interests
: A.E.C. has received consulting fees from AstraZeneca, Exagen Diagnostics and GlaxoSmithKline. A.M. has received consulting fees from Janssen and research grants from GlaxoSmithKline and Janssen. C.D. is supported by a GlaxoSmithKline award (ID 0000048412). E.S. has received honoraria from Janssen and Lilly. R.R.-G. has received research grants from Exagen Diagnostics and consulting fees from Thermo Fisher Scientific and Aurinia Pharmaceuticals. A.H. has received honoraria from AstraZeneca, Janssen and AbbVie, and research grant from Merck Serono. M.R.W.B has received consulting fees from AbbVie, Janssen, GlaxoSmithKline and Sanofi Genzyme. All other authors declare no competing interests.
